Handbook of Relapsing-Remitting Multiple Sclerosis

1. Front Matter

   Pages i-xii

   PDF

2. Multiple Sclerosis: An Overview

   • Robert Gross, Fred Lublin

   Pages 1-16

3. The Pathophysiology and Clinical Presentation of Multiple Sclerosis

   • Sam Horng, Michelle Fabian

   Pages 17-40

4. Assessment and Diagnosis of Relapsing Multiple Sclerosis

   • Rebecca Straus-Farber, Aaron Miller

   Pages 41-66

5. Treatment Strategies in Multiple Sclerosis

   • Asaff Harel, Ilana Katz-Sand

   Pages 67-97

6. Emerging Therapies in Multiple Sclerosis

   • Sylvia Klineova, Stephen Krieger

   Pages 99-113

7. Symptom Management in Multiple Sclerosis

   • Aliza Bitton Ben-Zacharia, Gretchen Mathewson

   Pages 115-134

This pocketbook is an evidence-based educational resource that provides a concise overview of diagnosis, treatment and long-term management of relapsing-remitting multiple sclerosis. An ideal clinical handbook for a wide range of medical professionals, this handbook includes international guidelines, clinically relevant clinical trial data, and an introduction to emerging therapies. Handbook of Relapsing-Remitting Multiple Sclerosis is a comprehensive overview of recent advances in this indication, enhanced by high quality figures and clinical images.

• Demyelination
• Immunotherapy
• Multilple sclerosis
• Neurology
• Relapse-remitting multiple sclerosis

“This is a well-considered and concise review of where we are currently ‘at’ with relapsing-remitting multiple sclerosis. … This is a reliable, practical introduction to the rapidly evolving and expanding area of multiple sclerosis, for those wishing to enter the ­field of neurologists seeking a better understanding of it.” (Victoria Singh-Curry, British Journal of Hospital Medicine, Vol. 78 (8), August, 2017)

• Icahn School of Medicine at Mount Sinai, New York, USA

  Aaron Miller

Dr. Aaron Miller is a member of the Board of Directors of the American Academy of Neurology, and serves as Editor of Continuum, the AAN's bimonthly continuing education publication. He is active in the New York City chapter of the National Multiple Sclerosis Society, where he serves as Chairman of the Clinical Advisory Committee. He is a past president of the Consortium of MS Centers, and was the first chairman of the Multiple Sclerosis section of the American Academy of Neurology. He has participated in numerous MS clinical trials, and is the principal investigator for several ongoing trials of new treatments at the CGD Center.

Policies and ethics